scorecardresearch
Friday, March 29, 2024
TopicDCGI

Topic: DCGI

DCGI approves anti-Covid drug developed by DRDO for emergency use

The drug has been developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), a leading laboratory of DRDO, in collaboration with Dr Reddy's Laboratories in Hyderabad.

DCGI to take decision on emergency use applications for foreign Covid vaccines in 3 days

The DCGI will issue permission for restricted emergency use on the condition that the vaccine be used according to guidelines under the National Covid-19 Vaccination Programme.

DCGI approves Russian Covid vaccine Sputnik for restricted emergency use in India

Sputnik V is to be administered intramuscularly to individuals aged 18 yrs & above in two doses of 0.5 ml each with an interval of 21 days.

Drug regulator DCGI extends shelf life of Covishield vaccine from 6 to 9 months

In a letter to the Serum Institute, Drugs Controller General of India Somani said the institute is permitted to apply the shelf life of 9 months to unlabeled vials available on hand.

‘No uniform test for cancer-causing substances in J&J baby products’ — drug regulator summoned

Child rights body issues summons over lack of standard testing methods to screen for presence of formaldehyde and asbestos in Johnson & Johnson’s baby shampoo and talcum powder.

Zee News on vaccine approval, Times Now on ‘green shoots’ in Indian economy

A quick take on what prime time TV news talked about.

Serum expects govt to sign pricing deal for Covishield within days

Officials have 'indicated orally' that first 100mn vaccines will be purchased at Rs 200 & a deal should be inked 'in next one or two days', according to Serum CEO Adar Poonawalla.

Strict follow-up, informed consent from recipients — conditions set for cleared Covid vaccines

India has given conditional emergency-use licence to two Covid vaccines — the Oxford-AstraZeneca candidate Covishield, and Bharat Biotech’s Covaxin.

Dr Reddy’s gets drug controller’s nod to conduct human clinical trial for Russian vaccine

Earlier in September 2020, Dr.Reddy's and Russian Direct Investment Fund entered into a partnership to conduct clinical trials of Sputnik V vaccine and its distribution in India.

Expert panel asks Dr Reddy’s to reapply for phase 2, 3 trials of Russian Covid vaccine

According to the CDSCO panel, the pharma company has to conduct both phase 2 and 3 clinical trials and cannot directly hold phase 3 trial for the vaccine in India, a source said.

On Camera

Profit margins in lottery industry are tiny. Here’s how Future Gaming paid for its electoral bonds

Neither state govts nor companies earn large profits from lotteries. However, a look at the system shows there’s ample evidence of murky dealings and financial irregularities. 

Amid plans to lift AFSPA, Army starts joint training with Jammu & Kashmir Police

In an interview with Gulistan News this week, Union Home Minister Amit Shah said the government would leave law and order to J&K Police and slowly withdraw troops.

For BJP, Kejriwal is an idea whose time has come to be destroyed

The ‘idea’ Kejriwal's politics grew around was a no-holds-barred fight against corruption. That is the reason Modi govt has now tarred him and his entire party with the same paint.